Synthesis and in vivo anti-ulcer evaluation of some novel piperidine linked dihydropyrimidinone derivatives

References

• Hoogerwerf WA, Paricha PJ. Pharmacotherapy of gastric acidity, peptic ulcer, and gastrointestinal reflux disease. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006:972.
   Google Scholar
• Robert A, Nezamis JE, Lancaster C, et al. Mild irritants prevent gastric necrosis through “adaptive cytoprotection” mediated by prostaglandins. Am J Physiol 1983;245:G113–21.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet 2009;374:1449–61.
   PubMed Web of Science ®Google Scholar
• Ahn JS, Eom CS, Jeon CY, Park SM. Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies. World J Gastroenterol 2013;19:2560–8.
   PubMed Web of Science ®Google Scholar
• Agrawal NM, Roth S, Graham DY, et al. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer: a randomized, controlled trial. Ann Intern Med 1991;115:195–200.
   PubMed Web of Science ®Google Scholar
• Lazzaroni M, Bianchi Porro G. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects. Dig Liver Dis 2001;33:S44–S58.
   PubMedGoogle Scholar
• Folkers K, Harwood HJ, Johnson TB. Researches on pyrimidines. cxxx. synthesis of 2-keto-1,2,3,4-tetrahydropyrimidines. J Am Chem Soc 1932;54:3751–8.
   Web of Science ®Google Scholar
• Atwal KS, Ahmed SZ, Bird JE, et al. Dihydropyrimidine angiotensin II receptor antagonists. J Med Chem 1992;35:4751–63.
   PubMed Web of Science ®Google Scholar
• Atwal KS, Swanson BN, Unger SE, et al. Dihydropyrimidine calcium channel blockers. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents. J Med Chem 1991;34:806–11.
   PubMed Web of Science ®Google Scholar
• Rovnyak GC, Kimball SD, Beyer BJ, et al. Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators. J Med Chem 1995;38:119–29.
   PubMed Web of Science ®Google Scholar
• Rana K, Kaur B, Chaudhary G. Synthesis and anti-ulcer activity of some dihydropyrimidines. Ind J Chem 2004;43B:1553–7.
   Google Scholar
• Patil A, Ganguly S, Surana S. Synthesis and antiulcer activity of 2-[5-substituted-1-H-benzo(d)imidazol-2-yl sulfinyl]methyl-3-substituted quinazoline-4-(3H) ones. J Chem Sci 2010;122:443–50.
   Web of Science ®Google Scholar
• Beena KP, Suresh R, Rajasekaranb A. Dihydropyrimidinones-a versatile scaffold with diverse biological activity. J Pharm Sci Res 2016;8:741–6.
   Google Scholar
• Bhat MA, Al-Dhfyan A, Al-Omar MA. Targeting cancer stem cells with novel 4-(4-substitutedphenyl)-5-(3,4,5-trimethoxy/3,4-dimethoxy)-benzoyl-3,4-dihydropyrimidine-2(1H)-one/thiones. Molecules 2016;21:1746–55.
   Web of Science ®Google Scholar
• Kodhati V, Vanga MR, Yellu NR. Synthesis and anti-bacterial and anti-ulcer evaluation of new S-mannich bases of 4,6-diaryl-3,4-dihydropyrimidin-2(1H)-thiones. J Korean Chem Soc 2013;57:234–40.
   Google Scholar
• Zhang X, Lei P, Sun T, et al. Design, synthesis, and fungicidal activity of novel thiosemicarbazide derivatives containing piperidine fragments. Molecules 2017;22:E2085.
   PubMed Web of Science ®Google Scholar
• Forcellini E, Boutin S, Lefebvre CA, et al. Synthesis and biological evaluation of novel quinazoline-4-piperidinesulfamide derivatives as inhibitors of NPP1. Eur J Med Chem 2018;147:130–49.
   PubMed Web of Science ®Google Scholar
• Kasturi SP, Surarapu S, Uppalanchi S, et al. Synthesis, molecular modeling and evaluation of α-glucosidase inhibition activity of 3,4-dihydroxy piperidines. Eur J Med Chem 2018;150:39–52.
   PubMed Web of Science ®Google Scholar
• Ferro S, Deri B, Germanò MP, et al. Targeting tyrosinase: development and structural insights of novel inhibitors bearing arylpiperidine and arylpiperazine fragments. J Med Chem 2018;61:3908–17.
   PubMed Web of Science ®Google Scholar
• Imaeda T, Ono K, Nakai K, et al. Discovery, synthesis, and structure-activity relations of 3,4-dihydro-1H-spiro(naphthalene-2,2'-piperidin)-1-ones as potassium-competitive acid blockers. Bioorg Med Chem 2017;25:3719–35.
   PubMed Web of Science ®Google Scholar
• Scott MK, Jacoby HI, Mills JE, et al. 4-(Diphenylmethyl)-1-[(imino)methyl]piperidines as gastric antisecretory agents. J Med Chem 1983;26:535–8.
   PubMed Web of Science ®Google Scholar
• Ivanov C, Petkov O, Petrov P. Synthesis, gastroprotective, antisecretory and anti-helicobacter effect of N-[3-(3-(1-piperidinylmethyl) phenoxy)propyl]-hydroxyacetamide 2-hydroxypropane-1,2,3-tricarboxylate bismuth (3+) complex (MX1)-MX1. J Pharm Pharmacol 1996;48:297–301.
   PubMed Web of Science ®Google Scholar
• Yu C, Mei XT, Zheng YP, Xu DH. Gastroprotective effect of taurine zinc solid dispersios against absolute ethanol-induced gastric lesions is mediated by enhancement of antioxidant activity and endogenous PGE2 production and attenuation of NO production. Eur J Pharmacol 2014;740:329–36.
   PubMed Web of Science ®Google Scholar
• Bhargava KP, Gupta MB, Tangri KK. Mechanism of ulcerogenic activity of indomethacin and oxyphenbutazone. Eur J Pharmacol 1973;22:191–5.
   PubMed Web of Science ®Google Scholar
• Senay EC, Levine RL. Synergism between cold and restraint for rapid production of stress ulcers in rats. Proc Soc Exp Biol Med 1967;124:1221–31.
   PubMed Web of Science ®Google Scholar
• Sashidhara KV, Avula SR, Mishra V, et al. Identification of quinoline-chalcone hybrids as potential antiulcer agents. Eur J Med Chem 2015;89:638–53.
   PubMed Web of Science ®Google Scholar
• Corne SJ, Morrissey SM, Woods RJ. Proceedings: a method for the quantitative estimation of gastric barrier mucus. J Physiol 1974;242:116P–17P.
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 1968;25:192–205.
   PubMed Web of Science ®Google Scholar
• Karber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exptl Pathol Pharmakol 1931;162:480–3.
   Google Scholar
• Bhat MA, Ahmed AF, Wen ZH, et al. Synthesis, anti-inflammatory and neuroprotective activity of pyrazole and pyrazolo[3,4-d]pyridazine bearing 3,4,5-trimethoxyphenyl. Med Chem Res 2017;26:1557–66.
   Web of Science ®Google Scholar
• Bhat MA, Al-Rashood KA, Abdel-Aziz HA. Unexpected configuration in stereoselective synthesis of some novel (1Z)-1-(morpholin-1-yl)-N2-arylamidrazones. Lett Org Chem 2012;9:487–92.
   Web of Science ®Google Scholar